Different Approaches to Modelling the Cost-effectiveness of Schistosomiasis Control

Memorias do Instituto Oswaldo Cruz

Volumn 93 SUPPL. 1, Issue , 1998, Pages 75-84

  Guyatt, Helen ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Control; Cost effectiveness analysis; Mathematical modelling; Morbidity; Schistosomiasis

Indexed keywords

SCHISTOSOMA MANSONI;

COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; REVIEW; SCHISTOSOMIASIS; THEORETICAL MODEL;

COST-BENEFIT ANALYSIS; HUMANS; MODELS, THEORETICAL; SCHISTOSOMIASIS;

EID: 0032238637     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761998000700010     Document Type: Article

References (14)

1. Chan MS 1997. The global burden of intestinal nematode infections: 50 years on. Parasitol Today 13: 438-443.
2. Chan MS. Bundy DAP 1997. Modelling the dynamic effects of community chemotherapy on patterns of morbidity due to Schistosoma mansoni. Trans R Soc Trop Med Hyg 91: 216-220.
3. Chan MS, Anderson RM, Medley GF, Bundy DAP 1996b. Dynamic aspects of morbidity and acquired immunity in schistosomiasis control. Acta Tropica 62: 105-117.
4. Chan MS, Guyatt HL, Bundy DAP, Booth M, Fulford AJC, Medley GF 1995. The development and validation of an age structured model for schistosomiasis transmission dynamics and control. Epidemiol Infect 115: 325-344.
5. Chan MS, Guyatt HL, Bundy DAP, Medley GF 1996a. Dynamic models of schistosomiasis morbidity. Am J Trop Med Hyg 55: 52-62.
6. Drummond MF, Stoddard TL, Torrance GW 1987. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, Oxford, 305 pp.
7. Guyatt HL, Chan MS 1998. An investigation into the interaction between drug efficacy and drug price of praziquantel in determining the cost-effectiveness of school-targeted treatment for Schistosoma mansoni using a population dynamic model. Trop Med Int Health 3: 425-435.
8. Guyatt HL, Evans D, Lengeler C, Tanner M 1994. Controlling schistosomiasis: the cost-effectiveness of alternative delivery strategies. Health Policy & Planning 9: 385-395.
9. Prescott NM 1987. The economics of schistosomiasis chemotherapy. Parasitol Today 3: 21-25.
10. Prescott NM, Warford J 1985. Economic appraisal in the health sector, p. 127-145. In K Lee, A Mills (eds), The Economics of Health in Developing Countries, Oxford University Press, Oxford.
11. Rosenfield PL, Smith RA, Wolman MG 1977. Development and verification of a schistosomiasis transmission model. Am J Trop Med Hyg 26: 505-516.
12. Stierle F 1994. Effectiveness and Costs of Integrated Schistosomiasis Control: an Example of the Bandiagara District, Republic of Mali, MBA Thesis. School of Management and Health Fconomics, Keele University, 127 pp.
13. World Bank 1993. World Development Report: Investing in Health. Oxford University Press, Oxford. 329 pp.
14. WHO - World Health Organization 1993. The Control of Schistosomiasis. Second Report of an Expert Committee. Technical Report Series no. 830. Geneva, 86 pp.